PharmaTher Holdings Ltd.
PHRRF · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $1 | $2 |
| Gross Profit | $0 | $0 | -$1 | -$2 |
| % Margin | – | – | – | – |
| R&D Expenses | $582 | $2,140 | $3,018 | $2,605 |
| G&A Expenses | $779 | $904 | $942 | $1,357 |
| SG&A Expenses | $942 | $904 | $942 | $1,357 |
| Sales & Mktg Exp. | $163 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,524 | $3,044 | $3,960 | $3,962 |
| Operating Income | -$1,524 | -$3,044 | -$3,960 | -$3,969 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2 | -$71 | -$2,456 | -$274 |
| Pre-Tax Income | -$1,526 | -$3,115 | -$6,416 | -$4,236 |
| Tax Expense | $0 | $0 | $0 | -$225 |
| Net Income | -$1,526 | -$3,115 | -$6,416 | -$4,011 |
| % Margin | – | – | – | – |
| EPS | -0.017 | -0.035 | -0.073 | -0.049 |
| % Growth | 51.3% | 51.5% | -47.4% | – |
| EPS Diluted | -0.02 | -0.035 | -0.073 | -0.049 |
| Weighted Avg Shares Out | 76,309 | 88,228 | 88,169 | 81,105 |
| Weighted Avg Shares Out Dil | 88,519 | 88,227 | 88,169 | 81,105 |
| Supplemental Information | – | – | – | – |
| Interest Income | $60 | $0 | $207 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $2 |
| EBITDA | -$1,523 | -$3,043 | -$3,958 | -$3,960 |
| % Margin | – | – | – | – |